A Valentine’s Day slasher stalks couples in this mash-up, which might be more impressive as a rom-com than a horror movie.

There was no shortage of colorful characters at Tempe Public Library's annual geek event.

Viva Street Style: At Laneway Festival 2025, Big Belts, Tiny Mini-Skirts & Leather Boots Displayed Uniformed Rebelliousness St Jerome’s Laneway Festival’s style credentials did not disappoint.

Shop-bought puff pastry, cheaper cuts of meat, stock, wine and cream. Bosh it together in a dish and serve with mash. Bloody wholesome and damn delicious. I decided to cosplay as a trad wife, and when ...

This got a further boost from the quest for meat substitutes, not to mention hilarious name-checks on the popular sketch comedy show, "Portlandia," and cosplay performers on "The Masked Singer." ...

Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

At 10.30am on a chilly Saturday the queue outside Manze’s pie-and-mash shop on Deptford High Street stretches 50 metres down the street. The restaurant has been a fixture of the south-east ...

Keep reading to learn about the link between obesity and MASH and how to reduce your risk of this disease. “MASH is a dysfunction of the liver caused by excess fat cells,” says Mir Ali ...

Potential competition from GLP-1 drugs and other MASH therapies exists, but REZDIFFRA's combination use and first-mover advantage mitigate these risks. Analysts project $515M in 2025 sales ...

A fan paid homage to Arlecchino through a cosplay, capturing the design of the character in real life. The next featured characters in Genshin Impact's banners after Mavuika will be Arlecchino and ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...